Key result
The addition of isosorbide dinitrate plus hydralazine to standard therapy significantly increases survival in black patients with advanced heart failure.
Why the study?
Does a fixed dose of isosorbide dinitrate plus hydralazine added to standard therapy increase survival in black patients with advanced heart failure?
Does a fixed dose of isosorbide dinitrate plus hydralazine added to standard therapy increase survival in black patients with advanced heart failure?
The combination of isosorbide dinitrate and hydralazine added to standard therapy increases survival in black patients with advanced heart failure.
Answers are grounded in this paper and cite their sources.
May support adding isosorbide dinitrate-hydralazine in black patients with advanced HF; leaves open broader applicability and mechanisms.
The addition of a fixed dose of isosorbide dinitrate plus hydralazine to standard therapy for heart failure including neurohormonal blockers is efficacious and increases survival among black patients with advanced heart failure.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2004) studied this question. The addition of isosorbide dinitrate plus hydralazine to standard therapy significantly increases survival in black patients with advanced heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: